ATTO Attovia Therapeutics, Inc.
Healthcare · Market cap: $690.7M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $52.4M | $4.5M |
| 2026-Q4 | $0 | $0 |
Bought$52.4M8 buy days
Sold$4.5M2 sell days
Net insider flow+$47.9Mnet buying · 5 years
Latest trade2026-08-06Redmile Group, LLC
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-08-06 | Buy | Redmile Group, LLC | 10% owner | 600,000 | $17.00 | $10.2M | 2 |
| 2026-08-06 | Buy | FHMLS XI, L.P. | 10% owner | 588,235 | $17.00 | $10.0M | 1 |
| 2026-08-06 | Buy | WALSH COLIN | Director | 500,000 | $17.00 | $8.5M | 1 |
| 2026-08-06 | Buy | GOLDMAN SACHS & CO. LLC | Other | 500,000 | $17.00 | $8.5M | 1 |
| 2026-08-06 | Buy | venBio Global Strategic Fund IV, L.P. | 10% owner | 382,352 | $17.00 | $6.5M | 1 |
| 2026-08-06 | Buy | Sanofi | 10% owner | 300,000 | $17.00 | $5.1M | 1 |
| 2026-08-05 | Sell | GOLDMAN SACHS & CO. LLC | Other | 105,607 | $21.28 | $2.2M | 22 |
| 2026-08-05 | Sell | WALSH COLIN | Director | 105,607 | $21.28 | $2.2M | 22 |
| 2026-08-05 | Buy | WALSH COLIN | Director | 85,000 | $21.00 | $1.8M | 1 |
| 2026-08-05 | Buy | GOLDMAN SACHS & CO. LLC | Other | 85,000 | $21.00 | $1.8M | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| GOLDMAN SACHS & CO. LLC | Other | $10.3M | $2.2M | 2026-08-06 |
| WALSH COLIN | Director | $10.3M | $2.2M | 2026-08-06 |
| Redmile Group, LLC | 10% owner | $10.2M | $0 | 2026-08-06 |
| FHMLS XI, L.P. | 10% owner | $10.0M | $0 | 2026-08-06 |
| venBio Global Strategic Fund IV, L.P. | 10% owner | $6.5M | $0 | 2026-08-06 |
| Sanofi | 10% owner | $5.1M | $0 | 2026-08-06 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-08-05 → 2026-08-06 | 6 | $52.4M | 51 | +14.7% (+13.3% raw) | -19.7% (-24.3% raw) | – | active |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.